Abstract:Previous study showed inhibition of RhoA and Rho kinase (ROCK) activity with fasudil could alleviate diabetes-induced cardiac dysfunction partially due to improvement of myocardial fibrosis. However, the effect of fasudil on intracellular calcium cycling and actin remodeling, both of which are important to regulate excitation-contract coupling, is still not fully elucidated. In this study, a diabetic cardiomyopathy model was induced by a single intraperitoneal injection of streptozotocin (STZ) in male Sprague Dawley rats. Diabetic rats were treated with fasudil or placebo for 8 weeks. We found that long-term administration of fasudil, a specific Rho kinase inhibitor, significantly ameliorated diabetes-induced contractile dysfunction both at cellular and whole organ levels. Fasudil-treated rats displayed improved diastolic intracellular calcium ([Ca2+]i) removal and rescued expression of protein responsible for [Ca2+]i clearance. Furthermore, our study indicated that fasudil treatment normalized the phosphorylation of the PKCβ2/Akt pathway in the diabetic heart, which might be the underlying mechanism accounting for the protective effect of fasudil on [Ca2+]i clearance. In addition, compared to the diabetes group, fasudil also normalized the G/F-actin ratio by preventing cofilin phosphorylation and promoted F-actin organization, suggesting a beneficial effect on actin remodeling. These findings indicate the protective effect of fasudil against diabetes-induced cardiac dysfunction via modulation of Ca2+ handling and actin remodeling. Overactivation of RhoA/ROCK plays a key role in the development of DCM. Inhibition of ROCK activity with fasudil improved [Ca2+]i removal in diabetic cardiomyocytes. Fasudil normalized the G/F-actin ratio and promoted F-actin organization. ROCK may be an excellent therapeutic target for the treatment of DCM.

Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases

Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases

Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms

Rho Kinase Inhibitor Fasudil Induces Neuroprotection and Neurogenesis Partially Through Astrocyte-Derived G-CSF

The Rho Kinase Inhibitor, Fasudil, Ameliorates Diabetes-Induced Cardiac Dysfunction by Improving Calcium Clearance and Actin Remodeling

FSD-C10: A More Promising Novel ROCK Inhibitor Than Fasudil for Treatment of CNS Autoimmunity.

Fasudil Protects Hippocampal Neurons Against Hypoxia-Reoxygenation Injury by Suppressing Microglial Inflammatory Responses in Mice.

Fasudil, a Rho Kinase Inhibitor, Drives Mobilization of Adult Neural Stem Cells after Hypoxia/reoxygenation Injury in Mice.

Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?

Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer's Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil

Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the tau transgenic mouse model of Alzheimer's disease

Fasudil Hydrochloride Could Promote Axonal Growth Through Inhibiting the Activity of Rock

ROCK Inhibitor Fasudil Attenuates Neuroinflammation and Associated Metabolic Dysregulation in the Tau Transgenic Mouse Model of Alzheimer's Disease

ROCK Inhibition with Fasudil Promotes Early Functional Recovery of Spinal Cord Injury in Rats by Enhancing Microglia Phagocytosis

Research Progress of the Therapeutic Effects of Fasudil, a Rho Kinase Inhibitor and Its Analogs, on Central Nervous System Diseases

Rho-kinase inhibition by fasudil modulates pre-synaptic vesicle dynamics

The Therapeutic Potential of Rho Kinase Inhibitor Fasudil Derivative FaD-1 in Experimental Autoimmune Encephalomyelitis

Fasudil, a Rho Kinase Inhibitor, Promotes the Autophagic Degradation of A53T Α-Synuclein by Activating the JNK 1/Bcl-2/Beclin 1 Pathway

Multitarget Intervention of Fasudil in the Neuroprotection of Dopaminergic Neurons in MPTP-mouse Model of Parkinson's Disease

Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.